Home » Authors » Cormac Sheridan

Articles by Cormac Sheridan

Crucell Lands EUR21M NIH Contract To Produce Ebola Virus Vaccine

April 20, 2005

By Cormac Sheridan

DNage Spun Out To Develop Therapies For Aging Diseases

April 20, 2005

By Cormac Sheridan

Crucell Lands EUR21M NIH Contract To Produce Ebola Virus Vaccine

April 20, 2005

By Cormac Sheridan

Karo Bio Falls As Merck Drops Second Compound From Deal

April 13, 2005

By Cormac Sheridan

Pharmexa Acquiring GemVax For Up To DKK73M In Shares

April 13, 2005

By Cormac Sheridan

Ipsat Therapies Raises EUR7M For Beta Lactam Antibiotic

April 13, 2005

By Cormac Sheridan

Pharmexa Acquiring GemVax For Up To DKK73M In Shares

April 13, 2005

By Cormac Sheridan

Ipsat Therapies Raises EUR7M For Beta Lactam Antibiotic

April 13, 2005

By Cormac Sheridan

Karo Bio Falls As Merck Drops Second Compound From Deal

April 13, 2005

By Cormac Sheridan

Borean Pharma Raises EUR4M For Program In Antibody Mimics

March 30, 2005

By Cormac Sheridan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...